Vicadrostat

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Vicadrostat is also known by a number of code names; one of the best known is BI 690517. This is an experimental low-molecular-weight drug which acts as an inhibitor of aldosterone and cortisol synthesis and is proposed for use in combination with the SGLT2 inhibitor empagliflozin (is abbreviated to VicaEmpa) to treat people with type 2 diabetes, high blood pressure, cardiovascular disease and kidney disease.

Vicadrostat is also known by a number of code names; one of the best known is BI 690517. This is an experimental low-molecular-weight drug which acts as an inhibitor of aldosterone and cortisol synthesis and is proposed for use in combination with the SGLT2 inhibitor empagliflozin (is abbreviated to VicaEmpa) to treat people with type 2 diabetes, high blood pressure, cardiovascular disease and kidney disease.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1374481199 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.